MC4R and fatty liver disease: Our study demonstrated that WD-fed MC4R KO mice had many characteristics in common with NASH patients, such as hepatic steatosis, increased Sirius Red-positive area, hepatic hydroxyproline content, fibrosis-related gene expression in the liver and plasma liver enzyme levels as reported previously [29, 30].